On September 7, 2013, the "2nd China·Jilin Pharmaceutical and Health Industry Development Forum—Chemical Drug Forum," jointly hosted by the China Biotechnology Development Center and the Jilin Provincial Department of Science and Technology, and organized by the Jilin Provincial Biopharmaceutical Industry Promotion Group Office and the Jilin Provincial Modern Traditional Chinese Medicine and Biopharmaceutical Base Construction Promotion Association, with co-organization from Jilin Bodaweiye Pharmaceutical Co., Ltd., was grandly held in Changchun. Zhang Weihan, Deputy Director of the Jilin Provincial Department of Science and Technology, attended the forum and delivered a speech. Leaders from the provincial science and technology department, representatives from member units of the provincial pharmaceutical industry promotion group, as well as officials responsible for pharmaceutical industry promotion or science and technology management from relevant cities (prefectures), counties (cities, districts), and over 200 participants—including leaders and R&D personnel from universities, research institutions, and pharmaceutical companies across the province—joined the event. The forum was chaired by Duan Chengjun, Chairman of Bodaweiye Pharmaceutical. This year’s forum focused primarily on the innovative development of new chemical drugs. Ding Jian, Director of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and an Academician of the Chinese Academy of Engineering, delivered the keynote speech. Additionally, five renowned experts presented at specialized forums: Du Guanhua, Researcher at the Drug Screening Center of Peking Union Medical College; Dr. Zhang Yongxiang, Deputy Minister/Researcher at the Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences; Dr. Zhang Yonghe, Deputy Director of the Peking University Sleep Medicine Center and Associate Director of the Department of Pharmacology at the School of Basic Medical Sciences; and Dr. Liu Jianxun, Chief Researcher at the China Academy of Chinese Medical Sciences and a leading expert in Chinese medicine and pharmacology in China.

On August 28, the finals of the third China Innovation and Entrepreneurship Competition—Jilin Regional Event, jointly hosted by the Jilin Provincial Department of Science and Technology and the Jilin Provincial Committee of the Communist Youth League, successfully concluded in Changchun. A total of 77 enterprises and teams from across the province participated in the competition. During the event, our company showcased our innovative achievements, business model, and future growth prospects. After rigorous evaluation, we were awarded second place in the enterprise category, earning priority support for relevant science and technology projects under the provincial department’s initiatives. Additionally, we were recommended to the Ministry of Science and Technology to compete in the national industry-level round of the third China Innovation and Entrepreneurship Competition. In the national industry-level competition held on September 27, our company once again demonstrated strong performance, securing fifth place in Group 4 and receiving the prestigious "Outstanding Enterprise Award." Awarded the Outstanding Enterprise Prize Competition Highlights Enterprise Showcase